1 / 54

Iron Status & Fatigue in the Endurance Athlete

Explore the impacts of low ferritin but normal Hb/Hct levels in a female college middle-distance runner experiencing fatigue and abdominal cramping. Understand the significance of iron supplements and diet in improving symptoms over time.

shauna
Download Presentation

Iron Status & Fatigue in the Endurance Athlete

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Iron Status & Fatiguein theEndurance Athlete • Should I get a serum ferritin?

  2. Example Case • RJ Dimeff. Clin J Sports Med 2000 • Female college middle-distance runner • CC: Fatigue, abdominal cramping • History, exam, labs unremarkable... • Low Ferritin with a “normal” Hb/Hct • Rx: Ferrous sulfate, iron-rich foods • Slowly gets better • Same song, second verse the following year

  3. Rowland, et al. (1989) • This study was very poorly done... • but was a catalyst for the concept of using Fe++ • supplements in endurance athletes • Convenience sample of girl H.S. runners • Pre-season & post-season • Traditional max tests (ramp protocol) • Time to volitional exhaustion • No control of training programs

  4. Fatigue Work-Up • History (>90% in athletes) • Exercise/Rest Provocative or Palliative? • Anxiety & Depression • Meds/Substance Abuse • Exam (<5%) • Infection/Inflammatory/Metabolic • Cardiopulmonary/Neuromuscular • Malignancy (PM/DM)

  5. JL Beard. J. Nutr. 131: 568S–580S, 2001.

  6. Fatigue Work-Up • Labs (5-10%) • CBC • UA • Complete Metabolic Profile • TSH • Consider ECG / CXR / OGTT • Rheum screen • ESR, CK, Rheumatoid Factor, ANA

  7. Overtraining...or maybe Iron? • Definition of fatigue vs endurance • Quantifying fatigue in the physiology lab • Studies of iron supplementation & fatigue • Iron metabolism • Fear & loathing (hemochromatosis) • A (not so) final analysis

  8. What is Fatigue? • Christensen, E.H. 1960. Muscular work and fatigue, in Muscle as a Tissue, eds. K.Rodahl, S.M.Horvath, New York, McGraw-Hill. • Physical fatigue: a state of disturbed homeostasis attributable to work and to work environment.

  9. What is Endurance? • Åstrand, P.-O., Rodahl, K., Dahl, H.A., Strømme, S.B. 2003. Textbook of Work Physiology, 4th edition. Champaign, IL. • No definition of endurance • Physical endurance - GEM definition: • A state of prolonged homeostasis despite elevated levels of external physical work; resistance to physical fatigue.

  10. What is Fatigue? • Characterization of exertional fatigue: • Muscle fatigue = 1/endurance • In situ / In vitro preparations • Multiple parameters needed to quantify • Highly sensitive to independent parameters • N.B.: SERCA the likely final common pathway

  11. What is Fatigue? • Loss of muscle contractility & lusitropy • Highly sensitive to independent parameters: • Tpass • Stimulation frequency (twitch vs tetanic) • O2 supply (ml O2 / min, not just Hb/Hct) • Other (e.g., sympathetic stimulation, pressors)

  12. JL Beard. J. Nutr. 131: 568S–580S, 2001.

  13. JL Beard. J. Nutr. 131: 568S–580S, 2001.

  14. Again, Fatigue is... • Loss of contractility and lusitropy • Highly sensitive to O2 supply • TCA cycle and Ox Phos pathways are notrate-limiting in the O2 transport chain and are in excess capacity, • It is unlikely that skeletal muscle iron-dependent compounds are related to fatigability during exercise therefore...

  15. OK...What About Humans? • Problem: no good objective measure of “muscle failure” • Volitional exhaustion • Relative intensity a critical factor • Max steady-state (i.e., Vt, [La]4 mM, etc.) • Poor control of non-oxidative energy contribution • Failure of contractility • Rhythmic isometric/isokinetic contractions • Low %MVC, low duty cycle • 1 contraction / 5 sec, electrical stimulation, etc.

  16. Fatigue in Humans? • Longitudinal studies are very problematic • Constant O2 supply? • Increase in Hb increases O2 delivery • Constant fitness? • Constant absolute vs relative intensity? • Constant non-oxidative contribution? • Existing studies do two interventions • Training • Iron supplementation

  17. Haas, et al. • Examine effect of Fe++ supplements on running economy • Examine effect of Fe++ supplements and training on virtual time-trial performance • Examine effect of Fe++ supplements on isokinetic contractility of knee extensors (not electrically stimulated) • Examine effect of Fe++ supplements on ventilatory threshold in trained subjects

  18. Haas group. Am J Clin Nutr. 1997. 66:334-341.

  19. Hinton et al., (Haas group). JAP. 2000. 88:1103-1111.

  20. Hinton et al., (Haas group). JAP. 2000. 88:1103-1111.

  21. Hinton et al., (Haas group). JAP. 2000. 88:1103-1111.

  22. Brutsaert et al. (Haas group). Am J Clin Nutr. 2003. 77:441-448.

  23. Brutsaert et al. (Haas group). Am J Clin Nutr. 2003. 77:441-448.

  24. Brutsaert et al. (Haas group). Am J Clin Nutr. 2003. 77:441-448.

  25. Hinton & Sinclair. Eur J Clin Nutr. 2007. 61:30-39.

  26. Iron / Fatigue Research • Difficult studies, but fatally-flawed designs • Hb increases with Fe++ supplements • Little/no control of relative intensity • Various inequalities between groups • Multiple interventions (exercise and Fe++) • Volitional fatigue • Vt effect? - possibly but Vt ≠ fatigue

  27. Iron Metabolism • Could sub-normal iron metabolism contribute to fatigue via non-O2 transport mechanisms? • What does ferritin do, anyway?!

  28. JL Beard. J Nutr 2001; 131: 568S–580S.

  29. JL Beard. J Nutr. 2001; 131: 568S–580S.

  30. Ponka, et al. Semin Hematol. 1998; 35:35-54.

  31. EC Thiel. J Nutr. 2003; 133:1549S-1553S. Ryter & Tyrrell. Free Rad Bio Med. 2000; 28:289-309.

  32. Ponka, et al. Semin Hematol. 1998; 35:35-54.

  33. Ryter & Tyrrell. Free Rad Bio Med. 2000; 28:289-309.

  34. Smith & Roberts. Clin Chem. 1994. 27:335-440.

  35. Forget About Ferritin? • Well,...no. It can be dangerous. • Hemochromatosis genotypes (HFE mutations) are highly prevalent in the population - one of the most common congenital mutations. • There continue to be no case-reports of a runner with phenotypic hemochromatosis. • Never is a long time.

  36. Athletes: 50 pro cyclists + 15 “Olympic class endurance runners” (vs only cyclists in Deugnier et al. MSSE. 2002; 34:876-880.) Chicharro, et al. Br J Sports Med. 2004; 38:418-421.

  37. Forget About Ferritin? • Ferritin gene knockout - lethal in utero • Population prevalence of HFE - 33% • Athlete prevalence of HFE - 50% • Could the hemochromatosis gene be protective against iron-deficiency in runners?

  38. Non-O2 Transport Fe++? • CNS structures that contain Fe++ • Cortex, striatum, cerebellum, thalamus • Fe++ a co-factor in myelination • Dopaminergic regions “affected” ≥15% low • Mesolimbic & striatonigral tracts • Motor control, perception, motivation • Serotonin/Norepinephrine - not affected

More Related